Clinical Trials · NCT01293292
Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Enrollment
- 19
- Start date
- Jan 2011
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Volumetric bone mineral density (BMD) of the lumbar spine (mg hydroxyapatite/cm3)